Abstract:Purpose: Fibrin glue (FG) has been used as a delivery system for bioactive agents on grafts and angioplasty sites. Reports from two different institutions suggest that heparin concentrations of 500 U/mL in FG inhibit smooth muscle cell (SMC) proliferation, but do not effect endothelial cell (EC) proliferation. The purposes of this study were to (1) quantify the diffusive release of fibroblast growth factor-1 (FGF-1) and heparin from FG; (2) determine the effect of heparin and FGF-1 on SMC proliferation when the cells are immediately plated on the FG; and (3) by means of the diffusive release data, design a new in vitro model that may differentiate the effect of FG-incorporated FGF-1 and heparin, rather than the released, solubilized components of these two factors, on SMC and EC proliferation. Methods: 125I-FGF-1 or 3H-heparin release from FG into the overlying media was measured serially in a 96-hour period, either with or without cells. SMCs were immediately plated on FG containing various concentrations of FGF-1 and heparin. SMCs or ECs were plated on identical groups of FG containing FGF-1 and heparin 24 hours after the FG was made to exclude the effect on cell growth of the initial release of FGF-1 into the media. Results: In the first 24 hours, 70% +/- 1% of the FGF-1 and 59% +/- 2% of the heparin in the FG was released into the overlying media, with minimal release occurring thereafter. The cell type or absence of cells did not affect release, but there was five times more FGF-1 and four times more heparin in the media at 72 hours for the immediate plating versus the delayed plating because of a diffusive release primarily in the first 24 hours. A heparin concentration of 500 U/mL inhibited SMC proliferation, as compared with 5 U/mL heparin, only when immediate plating of SMCs was used. Comparing immediate versus delayed SMC plating, at equivalent FGF-1 and heparin doses, immediate plating induced greater proliferation than delayed plating; this was likely caused by the higher soluble FGF-1 concentration. Heparin doses as high as 500 U/mL had little effect on SMC proliferation. In contrast, ECs died with delayed plating on FG containing 500 U/mL heparin, and their growth was inhibited at 50 U/mL heparin, as compared with 5 U/mL heparin. Conclusion: The differences in SMC proliferation when comparing immediate versus delayed plating are likely caused by diffusive release of heparin and FGF-1 into the media. Our ongoing work uses an optimized in vitro FG system that minimizes the effects of soluble factors. This is an important distinction, because the cytokines that are released in vivo will be removed by blood flow and, thus, may not exert an effect unless they are contained within the FG.

Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions

In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

Improved Endothelialization of Vascular Grafts by Local Release of Growth Factor from Heparinized Collagen Matrices

R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue

The use of commercial fibrin glue in dermal replacement material reduces angiogenic and lymphangiogenic gene and protein expression in vitro

Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors

Promotion of angiogenesis by sustained release of rhGM-CSF from heparinized collagen/chitosan scaffolds.

Angiogenesis is Enhanced by Sustained Delivery of rhGM-CSF from Porous Collagen-Chitosan Scaffolds

Release Kinetics and Cellular Profiles for Bfgf-Loaded Electrospun Fibers: Effect of the Conjugation Density and Molecular Weight of Heparin

Binding and Release of Basic Fibroblast Growth Factor from Heparinized Collagen Matrices.

Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1

Effects of Fibrin Glue on Proliferation,Migration and Ischemic Hypoxia Protection of Marrow-derived Cardiac Stem Cell

Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation

Conjugation of Basic Fibroblast Growth Factor on a Heparin Gradient for Regulating the Migration of Different Types of Cells.

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate loaded with basic fibroblast growth factor.

Sulfonated Copolymers as Heparin-Mimicking Stabilizer of Fibroblast Growth Factor: Size, Architecture, and Monomer Distribution Effects

Effect of Vegf and Bfgf Concentration Gradient on Proliferation and Migration of Vascular Endothelial Cells and Fibroblast

Development of a surface to enhance the effectiveness of fibroblast growth factor 2 (FGF-2)

Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta

Studies of Marine Sulfated Polymannuroguluronate on Endothelial Cell Proliferation and Endothelial Immunity and Related Mechanisms